Concordant inter-laboratory derived concentrations of ceramides in human plasma reference materials via authentic standards.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
    • Publication Information:
      Original Publication: [London] : Nature Pub. Group
    • Subject Terms:
    • Abstract:
      In this community effort, we compare measurements between 34 laboratories from 19 countries, utilizing mixtures of labelled authentic synthetic standards, to quantify by mass spectrometry four clinically used ceramide species in the NIST (National Institute of Standards and Technology) human blood plasma Standard Reference Material (SRM) 1950, as well as a set of candidate plasma reference materials (RM 8231). Participants either utilized a provided validated method and/or their method of choice. Mean concentration values, and intra- and inter-laboratory coefficients of variation (CV) were calculated using single-point and multi-point calibrations, respectively. These results are the most precise (intra-laboratory CVs ≤ 4.2%) and concordant (inter-laboratory CVs < 14%) community-derived absolute concentration values reported to date for four clinically used ceramides in the commonly analyzed SRM 1950. We demonstrate that calibration using authentic labelled standards dramatically reduces data variability. Furthermore, we show how the use of shared RM can correct systematic quantitative biases and help in harmonizing lipidomics. Collectively, the results from the present study provide a significant knowledge base for translation of lipidomic technologies to future clinical applications that might require the determination of reference intervals (RIs) in various human populations or might need to estimate reference change values (RCV), when analytical variability is a key factor for recall during multiple testing of individuals.
      (© 2024. The Author(s).)
    • References:
      Arterioscler Thromb Vasc Biol. 2016 Dec;36(12):2424-2430. (PMID: 27765765)
      Eur Heart J. 2016 Jul 01;37(25):1967-76. (PMID: 27125947)
      Anal Chim Acta. 2020 Nov 15;1137:74-84. (PMID: 33153611)
      Adv Exp Med Biol. 2020;1274:101-135. (PMID: 32894509)
      Anal Bioanal Chem. 2020 Apr;412(10):2191-2209. (PMID: 31820027)
      EJIFCC. 2016 Feb 09;27(1):30-6. (PMID: 27683504)
      Anal Chem. 2021 Dec 14;93(49):16369-16378. (PMID: 34859676)
      Cell Mol Life Sci. 2012 Jul;69(13):2135-46. (PMID: 22294100)
      J Lipid Res. 2020 Dec;61(12):1539-1555. (PMID: 33037133)
      J Lipid Res. 2021;62:100127. (PMID: 34582882)
      Nat Metab. 2019 Aug;1(8):745-747. (PMID: 32694765)
      Clin Chem. 1983 Jan;29(1):25-30. (PMID: 6848276)
      J Chromatogr A. 2011 Dec 30;1218(52):9366-74. (PMID: 22119139)
      J Lipid Res. 2018 Oct;59(10):2001-2017. (PMID: 30115755)
      Talanta. 2021 Aug 15;231:122367. (PMID: 33965032)
      J Lipid Res. 2017 Dec;58(12):2275-2288. (PMID: 28986437)
      Analyst. 2021 Apr 26;146(8):2591-2599. (PMID: 33734229)
      Anal Bioanal Chem. 2020 Apr;412(10):2375-2388. (PMID: 32078000)
      Diabetes. 2013 Feb;62(2):401-10. (PMID: 23139352)
      Anal Bioanal Chem. 2020 Nov;412(27):7373-7380. (PMID: 32851459)
      Metabolomics. 2022 Apr 9;18(4):24. (PMID: 35397018)
      J Biol Chem. 2022 Aug;298(8):102185. (PMID: 35753355)
      PLoS Biol. 2020 Sep 28;18(9):e3000870. (PMID: 32986697)
      Nat Commun. 2021 Aug 6;12(1):4771. (PMID: 34362906)
      Am J Clin Nutr. 2016 Sep;104 Suppl 3:907S-12S. (PMID: 27534625)
      Int J Neonatal Screen. 2020 Sep 17;6(3):75. (PMID: 33123642)
      J Lipid Res. 2020 Apr;61(4):537-545. (PMID: 32060071)
      J Appl Lab Med. 2022 Jun 30;7(4):863-870. (PMID: 35092283)
      Anal Chem. 2013 Dec 17;85(24):11732-8. (PMID: 24187941)
      Clin Biochem Rev. 2007 Nov;28(4):139-47. (PMID: 18392124)
      Nat Commun. 2019 Sep 24;10(1):4329. (PMID: 31551469)
      Diabetes. 2009 Feb;58(2):337-43. (PMID: 19008343)
      Anal Chem. 2019 Nov 19;91(22):14407-14416. (PMID: 31638379)
      Anal Chem. 2017 Jan 3;89(1):656-665. (PMID: 27959516)
      J Lipid Res. 2020 Jan;61(1):105-115. (PMID: 31732502)
      Anal Chem. 2019 Mar 5;91(5):3459-3466. (PMID: 30707563)
      Mass Spectrom Rev. 2017 Jan;36(1):58-85. (PMID: 26919394)
      J Clin Invest. 2020 Mar 2;130(3):1363-1376. (PMID: 31743112)
      Clin Chem Lab Med. 2019 May 27;57(6):864-872. (PMID: 30485171)
      Metabolites. 2021 Sep 30;11(10):. (PMID: 34677390)
      Hum Mol Genet. 2021 Apr 30;30(6):500-513. (PMID: 33437986)
      J Lipid Res. 2021;62:100138. (PMID: 34662536)
      Pharmacol Res. 2008 Jul;58(1):45-51. (PMID: 18611440)
      Anal Chem. 2013 Dec 17;85(24):11725-31. (PMID: 24147600)
      J Med Chem. 2021 Jan 14;64(1):279-297. (PMID: 33395289)
      Anal Bioanal Chem. 2016 May;408(13):3475-83. (PMID: 26922344)
      Clin Chem. 2020 Dec 1;66(12):1558-1561. (PMID: 34214151)
      Semin Nephrol. 2022 May;42(3):151281. (PMID: 36404212)
      J Proteome Res. 2020 Jul 2;19(7):2717-2731. (PMID: 31978300)
      Anal Bioanal Chem. 2020 Jun;412(15):3573-3584. (PMID: 32240327)
      PLoS One. 2019 Nov 20;14(11):e0224496. (PMID: 31747417)
      Nutrients. 2023 Jan 02;15(1):. (PMID: 36615886)
      J Lipid Res. 2010 Nov;51(11):3299-305. (PMID: 20671299)
    • Grant Information:
      PG/2019/34923 United Kingdom BHF_ British Heart Foundation
    • Accession Number:
      0 (Ceramides)
    • Publication Date:
      Date Created: 20241003 Date Completed: 20241003 Latest Revision: 20241204
    • Publication Date:
      20241204
    • Accession Number:
      PMC11449902
    • Accession Number:
      10.1038/s41467-024-52087-x
    • Accession Number:
      39362843